Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2032 of 6351
-
Scientists build atlas of Pre-Cancerous lung lesions to stop cancer before it starts
Knowledge-focused OngoingThis protocol pertains specifically to the prospective lung squamous cell carcinoma pre-malignant lesion (PML) cohort that will form a primary study group for the Lung Pre-Cancer Atlas.
Sponsor: University of Colorado, Denver • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
New drug combo targets brain tumors with genetic flaw
Disease control OngoingThis study will test the safety of the study drug, GDC-0084, in combination with radiation therapy in people who have solid tumor brain metastases or leptomeningeal metastases. All participants will have cancer with a PIK3CA mutation. The researchers will test increasing doses of…
Phase 1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Mass screening in bhutan aims to stop stomach cancer before it starts
Knowledge-focused CompletedBackground: Helicobacter pylori is a major risk factor for gastric cancer, yet in many developing countries, including Bhutan where gastric cancer incidence is high, access to screening and eradication is limited. The investigators conducted the first large-scale, population-base…
Sponsor: Zero Helicobacter IGAN Network • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:54 UTC
-
Can High-Dose amoxicillin be made safer?
Knowledge-focused CompletedAmoxicillin is the most prescribed antibiotic in France. High dose intravenous amoxicillin, (dosage greater than or equal to 150 mg / kg / day or 12 g per day for patients over 80 kg) is used in the treatment, in particular, of infectious streptococcal endocarditis. oral, strepto…
Phase 4 • Sponsor: University Hospital, Clermont-Ferrand • Aim: Knowledge-focused
Last updated Aug 09, 2026 00:00 UTC
-
Old drug, new hope: cabergoline trial targets endometriosis pain
Symptom relief CompletedEndometriosis is dependent on angiogenesis (the sprouting of new blood vessels) for its growth and maintenance, but the side effects of currently approved angiogenesis inhibitors make these agents inappropriate for use in reproductive-age patients. This obstacle will be overcome …
Phase 2 • Sponsor: Boston Children's Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
New gout drug shows promise in lowering uric acid levels
Disease control CompletedThe aim of this 12-week randomized multicenter double-blind parallel group placebo-controlled dose finding study is to assess the efficacy and safety of three different doses of LC350189 in subjects with hyperuricemia and a diagnosis of gout.
Phase 2 • Sponsor: LG Chem • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Can a questionnaire reveal the hidden burden of a rare genetic disease in women?
Knowledge-focused Recruiting nowX-linked adrenoleukodystrophy (X-ALD) is a hereditary white matter disorder caused by mutations in the ABCD1 gene leading to disturbances in the metabolism of fatty acids. This results in an accumulation of very long chain fatty acids (VLCFA) in the cells of the body causing dama…
Sponsor: Leipzig University Medical Center • Aim: Knowledge-focused
Last updated Aug 29, 2026 00:00 UTC
-
Could less radiation be better for nasopharyngeal cancer patients?
Disease control OngoingTo evaluate the long-term locoregional control, survival rate, late toxicity and quality of life after reducing the target volume in patients with locoregionally advanced nasopharyngeal carcinoma patients treated with induction chemotherapy plus concurrent chemoradiotherapy.
Phase 3 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 26, 2026 13:24 UTC
-
Blood test could spare kidney patients painful biopsies
Diagnosis Recruiting nowDemonstrate the relationship between DD-cfDNA levels and HLA antibodies in blood, and the Molecular Microscope® (MMDx) Diagnostic System results in indication biopsies.
Sponsor: University of Alberta • Aim: Diagnosis
Last updated Jun 27, 2026 13:00 UTC
-
Can a common sedative shield your brain after bypass surgery?
Disease control Recruiting nowAnesthesia is a drug induced, reversible, comatose state that facilitates surgery and it is widely assumed that cognition returns to baseline after anesthetics have been eliminated. However, many patients have persistent memory impairment for weeks to months after surgery. Cardia…
Phase 4 • Sponsor: Sunnybrook Health Sciences Centre • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Ovarian cancer drug niraparib tested in 850 korean women
Disease control Completed1. To evaluate the efficacy and safety of niraparib in Korean women with primary and recurrent epithelial ovarian cancer who underwent niraparib maintenance therapy 2. To evaluate the efficacy and safety of salvage niraparib therapy in Korean women with heavily pretreated epithel…
Sponsor: Asan Medical Center • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Aspirin and immune boosters could help fight prostate cancer before surgery
Disease control OngoingThis phase II trial studies how well enteric-coated (EC) aspirin and rintatolimod with or without interferon-alpha 2b work in treating patients with prostate cancer before surgery. EC Aspirin may help to keep the prostate cancer from coming back. Rintatolimod may stimulate the im…
Phase 2 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
New injection could help kids with lupus avoid flares
Disease control OngoingThe purpose of this study is to evaluate the pharmacokinetics (PK), safety, and pharmacodynamics (PD) of repeat doses of 200 milligrams per milliliter (mg/mL) belimumab administered via SC injection in pediatric participants 5 to 17 years of age with SLE on a background of standa…
Phase 2 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
Stroke study tests best anesthesia for clot removal
Disease control Recruiting nowSEACOAST 1 is a prospective, randomized, blinded endpoint trial comparing collateral vigor and clinical outcomes, with different forms of GA in patients with acute ischemic stroke due to anterior circulation large vessel occlusion (LVO) undergoing mechanical thrombectomy. The stu…
Sponsor: University of California, Los Angeles • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Can your favourite songs ease dementia symptoms? new study investigates
Symptom relief Recruiting nowThere is growing evidence for the benefits of music for individuals living with dementia but there has been limited research looking specifically at personalised music. Methodologies have not yet been developed to generate and play personalised music playlists quickly and cost ef…
Sponsor: Music for my Mind • Aim: Symptom relief
Last updated Jun 27, 2026 07:52 UTC
-
Blood pressure tweak during stroke procedure could save brains
Disease control OngoingStroke is the third most common cause of death in New Zealand and is one of the leading causes of long-term disability at all ages. A life-saving clot retrieval procedure can save lives and prevent disability of patients with ischaemic stroke who get to hospital in time. In New Z…
Sponsor: Auckland City Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Could sound waves help fight addiction? new trial explores ultrasound for opioid use
Disease control Recruiting nowThe purpose of this clinical trial is to investigate Low Intensity Focused Ultrasound (LIFU) using the Exablate® Model 4000 Type 2.0/2.1 as an adjunctive neuromodulatory treatment for OUD (Opioid Use Disorder) and/or other Substance Use Disorders (SUDs) by assessing its safety an…
Sponsor: InSightec • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
New blood test could spot type 1 diabetes before symptoms strike
Diagnosis OngoingThe purpose of this study is to measure the levels of certain substances (biomarkers) in the body that may indicate the triggers of Type 1 Diabetes, to find a better way to diagnose the disease, as well as to follow its progression.
Sponsor: AdventHealth Translational Research Institute • Aim: Diagnosis
Last updated Jun 27, 2026 12:02 UTC
-
New clotting factor combo aims to tame von willebrand bleeding
Disease control OngoingMOdalities of use, effectiveNEss and TOlerability of Eqwilate® a balanced combInatiON of VWF and FVIII in von WillEbrand patients in real-life conditions: the ONE-TO-ONE study
Sponsor: Octapharma • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Group prenatal care may cut diabetes risk for obese moms-to-be
Prevention CompletedTo conduct a randomized trial to determine the effect of Targeted Lifestyle Change Group Prenatal Care (TLC) on maternal and neonatal outcomes in women at high risk for developing gestational diabetes mellitus (GDM).
Sponsor: University of North Carolina, Chapel Hill • Aim: Prevention
Last updated Jun 27, 2026 09:06 UTC